| RPG Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532983 |
NSE Symbol : RPGLIFE |
P/E(TTM) : 33.07 |
|
ISIN Demat : INE105J01010 |
Div & Yield% : 1.08 |
EPS(TTM) : 67.39 |
|
Book Value(₹) : 334.94 |
Market Cap(₹Cr) : 3,686.22 |
Face Value(₹) : 8.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 181.68 | 168.92 | 143.09 | 172.71 | 172.21 | 165.42 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 181.68 | 168.92 | 143.09 | 172.71 | 172.21 | 165.42 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 15.76 | 5.23 | 114.96 | 3.31 | 1.94 | 2.37 |
| Total Income | 197.44 | 174.15 | 258.05 | 176.02 | 174.15 | 167.79 |
| Total Expenditure | 142.65 | 133.45 | 117.60 | 123.55 | 153.58 | 126.35 |
| PBIDT | 54.79 | 40.70 | 140.45 | 52.47 | 20.57 | 41.44 |
| Interest | 0.12 | 0.13 | 0.18 | 0.12 | 0.17 | 0.15 |
| PBDT | 54.67 | 40.57 | 140.27 | 52.35 | 20.40 | 41.29 |
| Depreciation | 5.22 | 5.14 | 5.37 | 5.46 | 5.31 | 5.29 |
| Tax | 11.56 | 9.07 | 17.48 | 11.92 | 10.78 | 9.51 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.04 | 0.07 | 0.07 | 0.04 | 0.11 | -0.27 |
| Reported Profit After Tax | 36.85 | 26.29 | 117.35 | 34.93 | 4.20 | 26.76 |
| Extra-ordinary Items | 8.36 | 0.00 | 95.60 | 0.00 | -16.41 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 28.49 | 26.29 | 21.75 | 34.93 | 20.61 | 26.76 |
| EPS (Unit Curr.) | 22.28 | 15.90 | 70.96 | 21.12 | 2.54 | 16.18 |
| EPS (Adj) (Unit Curr.) | 22.28 | 15.90 | 70.96 | 21.12 | 2.54 | 16.18 |
| Calculated EPS (Unit Curr.) | 22.28 | 15.90 | 70.96 | 21.12 | 2.54 | 16.18 |
| Calculated EPS (Adj) (Unit Curr.) | 22.28 | 15.90 | 70.96 | 21.12 | 2.54 | 16.18 |
| Calculated EPS (Ann.) (Unit Curr.) | 89.13 | 63.59 | 283.84 | 84.49 | 10.16 | 64.73 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 89.13 | 63.59 | 283.84 | 84.49 | 10.16 | 64.73 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 30.16 | 24.09 | 98.16 | 30.38 | 11.94 | 25.05 |
| PBDTM(%) | 30.09 | 24.02 | 98.03 | 30.31 | 11.85 | 24.96 |
| PATM(%) | 20.28 | 15.56 | 82.01 | 20.22 | 2.44 | 16.18 |